Q4 2021 Holdings
Filed 2022-02-14 | 39 holdings | $127.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $42.1M | 1,345,000 | 33.0% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $32.6M | 844,000 | 25.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $26.4M | 580,000 | 20.7% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $20.6M | 724,400 | 16.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.5M | 328,100 | 4.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $41.6K | 5,974,800 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $35.9K | 5,580,000 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $28.4K | 3,285,000 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $18.0K | 2,650,000 | 0.0% |
| Semler Scientific Inc(SMLR) | COM | 81684M104 | $15.8K | 172,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $15.7K | 2,526,500 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $15.5K | 265,750 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $12.1K | 1,025,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $11.7K | 342,000 | 0.0% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $11.5K | 1,435,510 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $10.2K | 2,385,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $10.1K | 680,000 | 0.0% |
| Merus N.V. | COM | N5749R100 | $10.1K | 317,800 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $9.5K | 883,602 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $9.4K | 3,750,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CLASS A | 75615P103 | $8.7K | 330,000 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $8.5K | 3,055,000 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA4EUR) | CLASS A SHARES | 37611X100 | $7.7K | 929,780 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.5K | 315,800 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $7.4K | 462,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $7.1K | 338,350 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $5.8K | 449,867 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $5.5K | 763,075 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $5.0K | 1,047,300 | 0.0% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $5.0K | 229,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $4.8K | 2,325,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.6K | 165,778 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $3.5K | 1,315,000 | 0.0% |
| Nucana PLC | SPONSORED ADR | 67022C106 | $2.8K | 1,189,000 | 0.0% |
| Avalo Therapeutics Inc | COM | 05338F108 | $2.5K | 1,459,400 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $2.1K | 850,000 | 0.0% |
| Aveo Biosciences Inc(0HJQ) | COM NEW | 053588307 | $1.2K | 263,400 | 0.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $82 | 16,800 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $34 | 16,667 | 0.0% |